期刊文献+

PEO-PPO嵌段共聚物抗肿瘤应用研究进展

Progress on Anti-tumor Application of PEO-PPO Block Polymers
下载PDF
导出
摘要 聚氧乙烯-聚氧丙烯(PEO-PPO)嵌段共聚物是一种理想并有前途的生物材料,因其优良的生物相容性和两亲性,广泛用于药物传递、疾病诊断和治疗等方面。PEO-PPO嵌段共聚物可通过自组装或与其他材料结合形成不同形态的纳米载体。近年,PEO-PPO嵌段共聚物对肿瘤区域的靶向性、解决肿瘤多药耐药性等问题被深入研究,且基于PEO-PPO-PEO型嵌段共聚醚(EPE型嵌段共聚醚)的多功能药物主动靶向载体在肿瘤治疗中应用越来越广泛,并根据肿瘤微环境的特点设计各种刺激响应型胶束,在抗肿瘤应用中取得重大进展。本文对基于PEO-PPO嵌段共聚物的给药系统在肿瘤治疗中的具体应用进行简要综述。 Poly(ethylene oxide)-poly(propylene oxide)(PEO-PPO)block polymers are ideal and promising biological material,which are widely applied in drug delivery,disease diagnosis and treatment due to their good biocompatibility and amphiphilic properties.PEO-PPO block polymers can form different kinds of nano carriers by self-assembling or combining with other materials.In recent years,the problems of targeting tumor region actively and solving multidrug resistance through applying PEO-PPO block polymers have been deeply studied.Besides,it is widespread to utilize multi-functional drug carriers based on PEO-PPO-PEO block polyethers(EPE block polyethers)in tumor treatment,and various stimulus-responsive micelles are developed according to the characteristics of the tumor microenvironment,resulting in great progress in anti-tumor application.In this paper,the specific applications of drug delivery system based on PEO-PPO block polymers in tumor therapy are briefly reviewed.
作者 王子潇 翁荣欣 袁树建 禹柳 吴倩倩 苏淮 WANG Zi-xiao;WENG Rong-xin;YUAN Shu-jian;YU Liu;WU Qian-qian;SU Huai(Shandong Freda Biotech Co.,Ltd,Jinan 250101,China;College of Life Sciences,Shandong Normal University,Jinan 250399,China)
出处 《食品与药品》 CAS 2023年第1期I0010-I0015,共6页 Food and Drug
关键词 PEO-PPO嵌段共聚物 抗肿瘤 多药耐药性 主动靶向 刺激响应型胶束 PEO-PPO block polymer anti-tumor multidrug resistance active targeting stimulus-responsive micelles
  • 相关文献

参考文献2

二级参考文献33

  • 1Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L.Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 2000;63: 19-30.
  • 2Lundberg BB, Risovic V, Ramaswamy M, Wasan KM. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Release 2003; 86: 93-100.
  • 3Alkan-Onyuksel H, Ramakrishnan S, Chai HB, Pezzuto JM. A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res 1994; 11: 206-12.
  • 4Liu Y, Chen GS, Chen Y, Cao DX, Ge ZQ, Yuan YJ. Inclusion complexes of paclitaxel and oligo(ethylenediamino) bridged bis (beta-cyclodextrin)s: solubilization and antitumor activity. Bioorg Med Chem 2004; 12: 5767-75.
  • 5Rodrigues P, Scheuermann K, Stockmar C, Maier G, Fiebig H,Unger C, et al. Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates. Bioorg Med Chem Lett 2003; 13: 355-60.
  • 6Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J Control Release 1993; 24:119-32.
  • 7Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Del Rev 2001; 47: 113-31.
  • 8Kabanov A, Batrakova E, Alakhov V. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug DelRev 2002; 54: 759-79.
  • 9Kabanov A, Batrakova E, Miller DW. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Del Rev 2003; 55: 151-64.
  • 10Croy SR, Kwon GS. The effects of Pluronic block copolymers on the aggregation state of nystatin. J Control Release 2004; 95:161-71.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部